Ocupation: Entrepreneur
Life: b. March 23, 1953
Birthday: March 23
Unfortunately our stock is somehow not well understood by the markets. The market compares us with generic companies. We need to look at Biocon as a bellwether stock. A stock that is differentiated, a stock that is focused on R&D, and a very-very strong balance sheet with huge value drivers at the end of it.
source: "Market needs to look at Biocon as a bellwether stock: Kiran Mazumdar Shaw". ET Now Interview, economictimes.indiatimes.com. April 26, 2013.
topic: Strong, Balance, Needs, Balance Sheets